Correlation Between Pfizer and Superior Plus

Can any of the company-specific risk be diversified away by investing in both Pfizer and Superior Plus at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Pfizer and Superior Plus into the same portfolio, which is an essential part of the fundamental portfolio management process.

By analyzing existing cross correlation between Pfizer Inc and Superior Plus Corp, you can compare the effects of market volatilities on Pfizer and Superior Plus and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Pfizer with a short position of Superior Plus. Check out your portfolio center. Please also check ongoing floating volatility patterns of Pfizer and Superior Plus.

Diversification Opportunities for Pfizer and Superior Plus

-0.18

Correlation Coefficient

Pfizer  Superior Plus

Good diversification

The 3 months correlation between Pfizer and Superior is -0.18. Overlapping area represents the amount of risk that can be diversified away by holding Pfizer Inc and Superior Plus Corp in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Superior Plus Corp and Pfizer is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Pfizer Inc are associated (or correlated) with Superior Plus. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Superior Plus Corp has no effect on the direction of Pfizer i.e., Pfizer and Superior Plus go up and down completely randomly.

Pair Corralation between Pfizer and Superior Plus

Assuming the 90 days horizon Pfizer Inc is expected to under-perform the Superior Plus. But the stock apears to be less risky and, when comparing its historical volatility, Pfizer Inc is 1.6 times less risky than Superior Plus. The stock trades about -0.1 of its potential returns per unit of risk. The Superior Plus Corp is currently generating about 0.03 of returns per unit of risk over similar time horizon. If you would invest  406.00  in Superior Plus Corp on December 30, 2024 and sell it today you would earn a total of  12.00  from holding Superior Plus Corp or generate 2.96% return on investment over 90 days.

Time Period	3 Months [change]
Direction	Moves Against
Strength	Insignificant
Accuracy	100.0%
Values	Daily Returns

Pfizer Inc  vs.  Superior Plus Corp

Pfizer Inc

Risk-Adjusted Performance

Very Weak

Over the last 90 days Pfizer Inc has generated negative risk-adjusted returns adding no value to investors with long positions. Despite latest weak performance, the Stock's basic indicators remain stable and the current disturbance on Wall Street may also be a sign of long-run gains for the company stockholders.

Superior Plus Corp

Risk-Adjusted Performance

Weak

Compared to the overall equity markets, risk-adjusted returns on investments in Superior Plus Corp are ranked lower than 2 (%) of all global equities and portfolios over the last 90 days. Despite nearly stable basic indicators, Superior Plus is not utilizing all of its potentials. The current stock price disturbance, may contribute to mid-run losses for the stockholders.

Pair Trading with Pfizer and Superior Plus

The main advantage of trading using opposite Pfizer and Superior Plus positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Pfizer position performs unexpectedly, Superior Plus can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Superior Plus will offset losses from the drop in Superior Plus' long position.

The idea behind Pfizer Inc and Superior Plus Corp pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.

Check out your portfolio center.

Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Equity Analysis module to research over 250,000 global equities including funds, stocks and ETFs to find investment opportunities.